# Dilapan-S®: A Multicenter US E-registry

> **NCT04451109** · — · ACTIVE_NOT_RECRUITING · sponsor: **Medicem Technology s.r.o.** · enrollment: 1200 (estimated)

## Conditions studied

- Post Term Pregnancy
- Premature Rupture of Membrane
- Fetal Growth Retardation
- Oligohydramnios
- Gestational Diabetes
- High Blood Pressure in Pregnancy

## Interventions

- **DEVICE:** Dilapan-S

## Key facts

- **NCT ID:** NCT04451109
- **Lead sponsor:** Medicem Technology s.r.o.
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-12-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-06-30
- **Target enrollment:** 1200 (ESTIMATED)
- **Last updated:** 2024-11-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04451109

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04451109, "Dilapan-S®: A Multicenter US E-registry". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04451109. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*